Gene Editing Companies Hit Back At Paper That Criticized CRISPR
June 12, 2017
June 12, 2017 | Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies. MIT Technology Review
CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our Privacy Policy for more information.
June 12, 2017 | Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies. MIT Technology Review